Stilbamidine

Stilbamidine

SCHEMBL889782

N=C(N)c1ccc(C=Cc2ccc(C(=N)N)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 3/20 1.00
PRMT5 O14744 1/20 1.00
ALDH1A1 P00352 1/20 1.00
HPGD P15428 1/20 1.00
CYP2C19 P33261 1/20 1.00
HSD17B10 Q99714 1/20 1.00
PLAU P00749 4/20 0.58
PLG P00747 1/20 0.58
PLAT P00750 1/20 0.58
KLK1 P06870 1/20 0.58
LMNA P02545 2/20 0.56
MASP2 O00187 1/20 0.56
THPO P40225 1/20 0.56
F2 P00734 7/20 0.54
PRSS1 P07477 2/20 0.54
PRSS3 P35030 2/20 0.54
APEX1 P27695 1/20 0.54
F10 P00742 6/20 0.52
F12 P00748 1/20 0.52
F7 P08709 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stilbamidine SCHEMBL208655 1.00 PRMT1 (1.00) PRMT1PRMT5ALDH1A1HPGDCYP2C19
Stilbamidine SCHEMBL3932459 0.97 PRMT1 (0.95) PRMT1PRMT5ALDH1A1HPGDCYP2C19
Stilbamidine SCHEMBL871695 0.95 PRMT1 (0.91) PRMT1PRMT5ALDH1A1HPGDCYP2C19
SCHEMBL428474 0.91 PRMT1 (0.83) PRMT1PRMT5ALDH1A1HPGDCYP2C19
SCHEMBL428473 0.91 PRMT1 (0.83) PRMT1PRMT5ALDH1A1HPGDCYP2C19
Hydrochloric Acid SCHEMBL11333159 0.89 PRMT1 (0.79) PRMT1PRMT5ALDH1A1HPGDCYP2C19
Hydrochloric Acid SCHEMBL11333164 0.89 PRMT1 (0.79) PRMT1PRMT5ALDH1A1HPGDCYP2C19
SCHEMBL2521983 0.89 PRMT1 (0.79) PRMT1PRMT5ALDH1A1HPGDCYP2C19
SCHEMBL23902148 0.87 PRMT1 (0.76) PRMT1PRMT5ALDH1A1HPGDCYP2C19
SCHEMBL2520059 0.85 ALDH1A1 (0.73) PRMT1PRMT5ALDH1A1HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-7310284-A None JP disclosed
US-8465921-B2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders ELITECH HOLDING B.V. (NL) 2013-06-18 US disclosed
US-8465921-B2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders ELITECH HOLDING B.V. (NL) 2013-06-18 US disclosed
US-20110275070-A1 HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS EPOCH PHARMACEUTICALS, INC. 2011-11-10 US disclosed
US-7794945-B2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders ELITECH HOLDING B.V. (NL) 2010-09-14 US disclosed
US-7556923-B1 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders EPOCH BIOSCIENCES, INC. (US) 2009-07-07 US disclosed
US-20090048427-A1 HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS EPOCH BIOSCIENCES, INC. (US) 2009-02-19 US disclosed
US-7297495-B2 Hybridization-triggered fluorescent detection of nucleic acids EPOCH BIOSCIENCES, INC. (US) 2007-11-20 US disclosed
US-7297495-B2 Hybridization-triggered fluorescent detection of nucleic acids EPOCH BIOSCIENCES, INC. (US) 2007-11-20 US disclosed
US-20070166723-A1 Hybridization-triggered fluorescent detection of nucleic acids EPOCH BIOSCIENCES INC. (US) 2007-07-19 US disclosed
US-20070166723-A1 Hybridization-triggered fluorescent detection of nucleic acids EPOCH BIOSCIENCES INC. (US) 2007-07-19 US disclosed
US-7163961-B1 Drugs, foods and oral compositions containing stilbene-type compounds SUNSTAR INC. (JP) 2007-01-16 US disclosed
EP-1161944-A1 DRUGS, FOODS AND ORAL COMPOSITIONS CONTAINING STILBENE-TYPE COMPOUNDS Sunstar Inc. (JP) 2001-12-12 EP disclosed
JP-H07310284-A ANTIMICROBIAL FIBROUS STRUCTURE TORAY IND INC 1995-11-28 JP disclosed
US-4716905-A Method of retrograde fluorescent labeling of neurons FLUOROCHROME, INC. (US) 1988-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070166723-A1 Hybridization-triggered fluorescent detection of nucleic acids DDX21, RNGTT, NOP2 PRMT1 4600/4885PRMT5 4481/4885ALDH1A1 3480/4885
US-20090048427-A1 HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS DDB1, LIG3, MSH2 PRMT1 4037/4885PRMT5 3830/4885ALDH1A1 4598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.